These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36405004)

  • 21. In search of models of pharmacoresistant epilepsy.
    Wahab A; Albus K; Gabriel S; Heinemann U
    Epilepsia; 2010 Jul; 51 Suppl 3():154-9. PubMed ID: 20618423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible interplay between the theories of pharmacoresistant epilepsy.
    Juvale IIA; Che Has AT
    Eur J Neurosci; 2021 Mar; 53(6):1998-2026. PubMed ID: 33306252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 2017 review of pharmacotherapy for treating focal epilepsy: where are we now and how will treatment develop?
    Schulze-Bonhage A
    Expert Opin Pharmacother; 2017 Dec; 18(17):1845-1853. PubMed ID: 29140112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of childhood epilepsy.
    Kalra V
    Indian J Pediatr; 2003 Feb; 70(2):147-51. PubMed ID: 12661810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of pharmacoresistant epilepsy.
    Hitiris N; Mohanraj R; Norrie J; Sills GJ; Brodie MJ
    Epilepsy Res; 2007 Jul; 75(2-3):192-6. PubMed ID: 17628429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiepileptic drugs and epileptic seizures].
    Karlov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(4):21-7. PubMed ID: 16737156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology aspects during transition and at transfer in patients with epilepsy.
    Chiron C; An I
    Epilepsia; 2014 Aug; 55 Suppl 3():8-11. PubMed ID: 25209078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.
    Campos G; Fortuna A; Falcão A; Alves G
    Epilepsy Res; 2018 Oct; 146():63-86. PubMed ID: 30086482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcomes of surgical treatment of patients with pharmacoresistant epilepsy].
    Krylov VV; Guekht AB; Trifonov IS; Lebedeva AV; Kaimovsky IL; Sinkin MV; Grigorieva EV; Grishkina MN; Shyshkina LV; Kochetkova OO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):13-18. PubMed ID: 28005041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies.
    Pati S; Alexopoulos AV
    Cleve Clin J Med; 2010 Jul; 77(7):457-67. PubMed ID: 20601619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABC Transporters and Drug Resistance in Patients with Epilepsy.
    Feldmann M; Koepp M
    Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurovascular Drug Biotransformation Machinery in Focal Human Epilepsies: Brain CYP3A4 Correlates with Seizure Frequency and Antiepileptic Drug Therapy.
    Williams S; Hossain M; Ferguson L; Busch RM; Marchi N; Gonzalez-Martinez J; Perucca E; Najm IM; Ghosh C
    Mol Neurobiol; 2019 Dec; 56(12):8392-8407. PubMed ID: 31243719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug-resistant partial epilepsy: pharmacological criteria].
    Bordet R
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S36-42. PubMed ID: 15331946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug-resistant epilepsy in adults].
    Loiseau P; Jallon P
    Rev Neurol (Paris); 1995 May; 151(5):295-306. PubMed ID: 7481386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modern antiepileptic drugs: guidelines and beyond.
    Hitiris N; Brodie MJ
    Curr Opin Neurol; 2006 Apr; 19(2):175-80. PubMed ID: 16538093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it.
    Łukawski K; Czuczwar SJ
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1075-1090. PubMed ID: 34310255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all.
    Delgado-Escueta AV; Bourgeois BF
    Epilepsia; 2008 Dec; 49 Suppl 9():13-24. PubMed ID: 19087113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New horizons in the development of antiepileptic drugs.
    Löscher W; Schmidt D
    Epilepsy Res; 2002 Jun; 50(1-2):3-16. PubMed ID: 12151112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
    Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
    Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-Level Monitoring on Admission for Presurgical Epilepsy Evaluation.
    Constantinescu I; Korff CM; Vulliemoz S; Picard F; Seeck M
    Eur Neurol; 2017; 78(1-2):105-110. PubMed ID: 28738370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.